[Cost-effectiveness analysis of peginterferon beta-1a in Italian relapsing remitting multiple sclerosis management]. (2016). Farmeconomia. Health Economics and Therapeutic Pathways, 17(2S), 13-36. https://doi.org/10.7175/fe.v17i2S.1230